225 related articles for article (PubMed ID: 1448912)
1. Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses.
Grambas S; Bennett MS; Hay AJ
Virology; 1992 Dec; 191(2):541-9. PubMed ID: 1448912
[TBL] [Abstract][Full Text] [Related]
2. Maturation of influenza A virus hemagglutinin--estimates of the pH encountered during transport and its regulation by the M2 protein.
Grambas S; Hay AJ
Virology; 1992 Sep; 190(1):11-8. PubMed ID: 1529523
[TBL] [Abstract][Full Text] [Related]
3. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
[TBL] [Abstract][Full Text] [Related]
4. Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles.
Steinhauer DA; Wharton SA; Skehel JJ; Wiley DC; Hay AJ
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11525-9. PubMed ID: 1763066
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations.
Abed Y; Goyette N; Boivin G
Antimicrob Agents Chemother; 2005 Feb; 49(2):556-9. PubMed ID: 15673732
[TBL] [Abstract][Full Text] [Related]
6. Influenza virus M2 protein ion channel activity is not required to maintain the equine-1 hemagglutinin in its native form in infected cells.
Takeuchi K; Shaughnessy MA; Lamb RA
Virology; 1994 Aug; 202(2):1007-11. PubMed ID: 7518161
[TBL] [Abstract][Full Text] [Related]
7. Influenza A virus M2 ion channel protein: a structure-function analysis.
Holsinger LJ; Nichani D; Pinto LH; Lamb RA
J Virol; 1994 Mar; 68(3):1551-63. PubMed ID: 7508997
[TBL] [Abstract][Full Text] [Related]
8. Regulation of pH by the M2 protein of influenza A viruses.
Ciampor F; Thompson CA; Grambas S; Hay AJ
Virus Res; 1992 Mar; 22(3):247-58. PubMed ID: 1626420
[TBL] [Abstract][Full Text] [Related]
9. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.
Wang C; Takeuchi K; Pinto LH; Lamb RA
J Virol; 1993 Sep; 67(9):5585-94. PubMed ID: 7688826
[TBL] [Abstract][Full Text] [Related]
10. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
Takeda M; Pekosz A; Shuck K; Pinto LH; Lamb RA
J Virol; 2002 Feb; 76(3):1391-9. PubMed ID: 11773413
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment.
Ciampor F; Bayley PM; Nermut MV; Hirst EM; Sugrue RJ; Hay AJ
Virology; 1992 May; 188(1):14-24. PubMed ID: 1566569
[TBL] [Abstract][Full Text] [Related]
12. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
13. Creation of amantadine resistant clones of influenza type A virus using a new transfection procedure.
Sweet TM; Maassab HF; Coelingh K; Herlocher ML
J Virol Methods; 1997 Dec; 69(1-2):103-11. PubMed ID: 9504756
[TBL] [Abstract][Full Text] [Related]
14. Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells.
Wang C; Lamb RA; Pinto LH
Virology; 1994 Nov; 205(1):133-40. PubMed ID: 7526533
[TBL] [Abstract][Full Text] [Related]
15. Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport.
Takeuchi K; Lamb RA
J Virol; 1994 Feb; 68(2):911-9. PubMed ID: 7507186
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
Li F; Ma C; Hu Y; Wang Y; Wang J
ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
[TBL] [Abstract][Full Text] [Related]
17. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers.
Sakai Y; Kawaguchi A; Nagata K; Hirokawa T
Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473
[TBL] [Abstract][Full Text] [Related]
18. Influence of residue 44 on the activity of the M2 proton channel of influenza A virus.
Betakova T; Ciampor F; Hay AJ
J Gen Virol; 2005 Jan; 86(Pt 1):181-184. PubMed ID: 15604445
[TBL] [Abstract][Full Text] [Related]
19. Investigation of a recent rise of dual amantadine-resistance mutations in the influenza A M2 sequence.
Durrant MG; Eggett DL; Busath DD
BMC Genet; 2015; 16 Suppl 2(Suppl 2):S3. PubMed ID: 25953496
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.
Ma C; Zhang J; Wang J
Mol Pharmacol; 2016 Sep; 90(3):188-98. PubMed ID: 27385729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
